<DOC>
	<DOCNO>NCT00484822</DOCNO>
	<brief_summary>Often necessary temporarily discontinue OAT surgical invasive procedure require . However , consensus optimal management situation , heparin bridge therapy current usual practice situation . No large randomize , control clinical trial yet perform evaluate efficacy safety low molecular weight heparin ( LMWH ) bridge therapy .</brief_summary>
	<brief_title>Bemiparin Randomized Trial Bridging Oral Anticoagulants Invasive Procedures ( BERTA Study )</brief_title>
	<detailed_description>THE MAIN OBJECTIVE study evaluate efficacy safety subcutaneous administration Bemiparin 3,500 IU , peri-operative procedural management patient require temporary interruption oral anticoagulation therapy ( OAT ) . PRIMARY EFFICACY ENDPOINT : combine incidence arterial venous thromboembolic event deaths cause within 3 month invasive procedure . PRIMARY SAFETY ENDPOINT : incidence major bleed within 10 day invasive procedure .</detailed_description>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>1 . Patients 18 year give informed consent participate study . 2 . Patients receive oral anticogulants least 3 month require outpatient surgery , laparoscopy surgery invasive procedure 3 . Procedures must perform 8 15 pm . 1 . Patients severe renal failure ( creatinine clearance &lt; 30 ml/min ) hepatic insufficiency ( AST and/or ALT &gt; 5 time normal value establish reference range local hospital laboratory ) . 2 . Patients show thromboembolic event appropriate INR . 3 . Known hypersensitivity LMWH , heparin substance porcine origin . 4 . Patients organic lesion susceptible bleeding ( e.g . active peptic ulcer , stroke , aneurysms ) . 5 . Patients history heparininduced thrombocytopenia . 6 . Patients suspect inability/or inability comply treatment and/or complete study . 7 . Patients participate another clinical trial participate past 30 day . 8 . Patients antithrombin deficit C S protein deficit 9 . Women pregnant breastfeeding , possibility become pregnant study . 10 . Acute bacterial endocarditis slow endocarditis . 11 . Severe arterial hypertension ( systolic blood pressure 200 mmHg and/or diastolic blood pressure 120 mmHg ) . 12 . Patients antiplatelet therapy 13 . Patients mechanical cardiac valve mitral position body weight 90 Kg with/or bone mass index ( BMI ) &gt; 30 50 kg 14 . Patients StarrEdwards valve .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>